BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raja MA, Mendoza MA, Villavicencio A, Anjan S, Reynolds JM, Kittipibul V, Fernandez A, Guerra G, Camargo JF, Simkins J, Morris MI, Abbo LA, Natori Y. COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature. Transplant Rev (Orlando). 2021;35:100588. [PMID: 33246166 DOI: 10.1016/j.trre.2020.100588] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Lerner AH, Klein EJ, Hardesty A, Panagiotou OA, Misquith C, Farmakiotis D. Comparison of COVID-19 outcomes in organ transplant recipients (OTr) and non-transplant patients: a study protocol for rapid review. Syst Rev 2021;10:299. [PMID: 34802460 DOI: 10.1186/s13643-021-01854-8] [Reference Citation Analysis]
2 An W, Wang Q, Kim T, Kang J. Clinical characteristics and outcome of coronavirus disease 2019 infection in patients with solid organ transplants: A systematic review and meta-analysis. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.02.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Navari Y, Bagheri AB, Akhavan Rezayat A, SeyedAlinaghi S, Najafi S, Barzegary A, Asadollahi-Amin A. Mortality risk factors in kidney-transplanted patients with COVID-19: A systematic review and regression analysis. Health Sci Rep 2021;4:e427. [PMID: 34761124 DOI: 10.1002/hsr2.427] [Reference Citation Analysis]
4 Camargo JF, Mendoza MA, Lin R, Moroz IV, Anderson AD, Morris MI, Natori Y, Natori A, Raja M, Lekakis L, Beitinjaneh A, Jimenez A, Goodman M, Wang T, Komanduri KV, Pereira D. Clinical presentation and outcomes of COVID-19 following hematopoietic cell transplantation and cellular therapy. Transpl Infect Dis 2021;:e13625. [PMID: 33896088 DOI: 10.1111/tid.13625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Opsomer R, Kuypers D. COVID-19 and solid organ transplantation: Finding the right balance. Transplantation Reviews 2022;36:100710. [DOI: 10.1016/j.trre.2022.100710] [Reference Citation Analysis]
6 Gatti M, Rinaldi M, Bussini L, Bonazzetti C, Pascale R, Pasquini Z, Faní F, Pinho Guedes MN, Azzini AM, Carrara E, Palacios-baena ZR, Caponcello G, Reyna-villasmil E, Tacconelli E, Rodríguez-baño J, Viale P, Giannella M, Caroccia N, Arbizzani F, Giacomini ME, Vatamanu O, Razzaboni E, De Rui ME, Gorska A, Maldonado N, Olivares P, Gutiérrez-campos D, Martín-gutiérrez AB, Palomo V, Serna A. Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.02.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Bajpai D, Deb S, Bose S, Gandhi C, Modi T, Katyal A, Saxena N, Patil A, Thakare S, Pajai AE, Haridas A, Keskar VS, Jawale SY, Sultan AG, Jamale TE. Recovery of kidney function after AKI because of COVID-19 in kidney transplant recipients. Transpl Int 2021;34:1074-82. [PMID: 33884672 DOI: 10.1111/tri.13886] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Vachtenheim J Jr, Novysedlak R, Svorcova M, Lischke R, Strizova Z. How COVID-19 Affects Lung Transplantation: A Comprehensive Review. J Clin Med 2022;11:3513. [PMID: 35743583 DOI: 10.3390/jcm11123513] [Reference Citation Analysis]
9 Yetmar ZA, Beam E, O'Horo JC, Ganesh R, Bierle DM, Brumble L, Seville MT, Razonable RR. Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients. Open Forum Infect Dis 2021;8:ofab255. [PMID: 34631921 DOI: 10.1093/ofid/ofab255] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wang RF, Fagelman EJ, Smith NK, Sakai T. Abdominal Organ Transplantation: Noteworthy Literature in 2020. Semin Cardiothorac Vasc Anesth 2021;25:138-50. [PMID: 33845699 DOI: 10.1177/10892532211007256] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Vinson AJ, Dai R, Agarwal G, Anzalone AJ, Lee SB, French E, Olex AL, Madhira V, Mannon RB; National COVID Cohort Collaborative (N3C) Consortium. Sex and organ-specific risk of major adverse renal or cardiac events in solid organ transplant recipients with COVID-19. Am J Transplant 2021. [PMID: 34637599 DOI: 10.1111/ajt.16865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
12 Kwapisz M, Małkowski P, Tronina O, Wasiak D, Czerwiński J, Polak WG, Kosieradzki M. Effects of the COVID-19 Pandemic on Solid Organ Transplantation During 2020 in Poland Compared with Countries in Western Europe, Asia, and North America: A Review. Med Sci Monit 2021;27:e932025. [PMID: 34480012 DOI: 10.12659/MSM.932025] [Reference Citation Analysis]
13 Jung A, Orenti A, Dunlevy F, Aleksejeva E, Bakkeheim E, Bobrovnichy V, Carr SB, Colombo C, Corvol H, Cosgriff R, Daneau G, Dogru D, Drevinek P, Vukic AD, Fajac I, Fox A, Fustik S, Gulmans V, Harutyunyan S, Hatziagorou E, Kasmi I, Kayserová H, Kondratyeva E, Krivec U, Makukh H, Malakauskas K, McKone EF, Mei-Zahav M, de Monestrol I, Olesen HV, Padoan R, Parulava T, Pastor-Vivero MD, Pereira L, Petrova G, Pfleger A, Pop L, van Rens JG, Rodic M, Schlesser M, Storms V, Turcu O, Woz Niacki L, Yiallouros P, Zolin A, Downey DG, Naehrlich L. Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe. ERJ Open Res 2021;7:00411-2021. [PMID: 34984210 DOI: 10.1183/23120541.00411-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chakravorty S, Cochrane AB, Psotka MA, Regmi A, Marinak L, Thatcher A, Shlobin OA, Brown AW, King CS, Ahmad K, Khangoora V, Singhal A, Nathan SD, Aryal S. CMV Infection Following mRNA SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplant Direct 2022;8:e1344. [PMID: 35706606 DOI: 10.1097/TXD.0000000000001344] [Reference Citation Analysis]
15 Ryu H, Narayanan N, Bhatt PJ. Prevention of infection and optimizing vaccination in the solid organ transplant candidate and recipient. Curr Opin Organ Transplant 2021;26:445-55. [PMID: 34227584 DOI: 10.1097/MOT.0000000000000902] [Reference Citation Analysis]
16 Doğan A, Doğan R, Menekli T, Berktaş HB. Effect of neuro-linguistic programming on COVID-19 fear in kidney transplant patients: A randomized controlled study. Complementary Therapies in Clinical Practice 2022. [DOI: 10.1016/j.ctcp.2022.101638] [Reference Citation Analysis]
17 Meshram HS, Kute VB, Patel H, Banerjee S, Navadiya V, Desai S, Rizvi SJ, Mishra V, Chauhan S. Feasibility and safety of remdesivir in SARS-CoV2 infected renal transplant recipients: A retrospective cohort from a developing nation. Transpl Infect Dis 2021;:e13629. [PMID: 33915006 DOI: 10.1111/tid.13629] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Gaussen A, Hornby L, Rockl G, O'Brien S, Delage G, Sapir-Pichhadze R, Drews SJ, Weiss MJ, Lewin A. Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation. Transplantation 2021;105:1405-22. [PMID: 33724248 DOI: 10.1097/TP.0000000000003744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Ross LF. COVID-19 Vaccine Refusal and Organ Transplantation. American Journal of Kidney Diseases 2022. [DOI: 10.1053/j.ajkd.2022.02.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Senefeld JW, Klassen SA, Ford SK, Senese KA, Wiggins CC, Bostrom BC, Thompson MA, Baker SE, Nicholson WT, Johnson PW, Carter RE, Henderson JP, Hartman WR, Pirofski LA, Wright RS, Fairweather L, Bruno KA, Paneth NS, Casadevall A, Joyner MJ. Use of convalescent plasma in COVID-19 patients with immunosuppression. Transfusion 2021;61:2503-11. [PMID: 34036587 DOI: 10.1111/trf.16525] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Loinaz-Segurola C, Marcacuzco-Quinto A, Fernández-Ruiz M. Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects. World J Hepatol 2021; 13(10): 1299-1315 [PMID: 34786167 DOI: 10.4254/wjh.v13.i10.1299] [Reference Citation Analysis]
22 Shafiq M, Gibson C. Clinical outcomes of coronavirus disease 2019 in liver transplant recipients. World J Hepatol 2022; 14(6): 1142-1149 [DOI: 10.4254/wjh.v14.i6.1142] [Reference Citation Analysis]
23 Avery RK. Update on COVID-19 Therapeutics for Solid Organ Transplant Recipients, Including the Omicron Surge. Transplantation 2022;106:1528-37. [PMID: 35700481 DOI: 10.1097/TP.0000000000004200] [Reference Citation Analysis]
24 Klomjit N, El Ters M, Adam BA, Sampathkumar P, Razonable RR, Taler SJ, Taner T, Alexander MP. Diffuse C4d staining of peritubular capillaries in renal allograft following bamlanivimab therapy. Am J Transplant 2021. [PMID: 34358400 DOI: 10.1111/ajt.16783] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Søfteland JM, Gisslén M, Liljeqvist JÅ, Friman V, de Coursey E, Karason K, Ekelund J, Felldin M, Magnusson J, Baid-Agrawal S, Wallquist C, Schult A, Jacobsson H, Bergdahl A, Bemark M, Andersson LM, Holm Gunnarsson I, Stenström J, Leach S. Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls. Am J Transplant 2021. [PMID: 34860447 DOI: 10.1111/ajt.16909] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Meshram HS, Kute V, Patel H, Banerjee S, Chauhan S, Desai S. Successful management of dengue in renal transplant recipients: A retrospective cohort from a single center. Clin Transplant 2021;35:e14332. [PMID: 33914386 DOI: 10.1111/ctr.14332] [Reference Citation Analysis]
27 Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:947-59. [PMID: 34966658 DOI: 10.14218/JCTH.2021.00228] [Reference Citation Analysis]
28 Conway J, Auerbach SR, Richmond ME, Sharp B, Pahl E, Feingold B, Azeka E, Dryer WJ, Cantor RS, Kirklin JK; Pediatirc Heart Transplant Society Investigators. Early report from the Pediatric Heart Transplant Society on COVID-19 infections in pediatric heart transplant candidates and recipients. J Heart Lung Transplant 2021:S1053-2498(21)02582-1. [PMID: 34903451 DOI: 10.1016/j.healun.2021.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
29 Russo G, Lai Q, Poli L, Perrone MP, Gaeta A, Rossi M, Mastroianni CM, Garofalo M, Pretagostini R. SARS-COV-2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications. Clin Transplant 2021;:e14495. [PMID: 34569101 DOI: 10.1111/ctr.14495] [Reference Citation Analysis]
30 Laothamatas K, Hum J, Benvenuto L, Shah L, Grewal HS, Pereira M, Scheffert J, Carroll M, Nolan M, Reilly G, Lemaitre P, Stanifer BP, Sonett JR, D’ovidio F, Robbins H, Arcasoy SM. One Year Into the Pandemic: Evolving COVID-19 Outcomes in Lung Transplant Recipients, a Single-center Experience. Transplantation Direct 2022;8:e1296. [DOI: 10.1097/txd.0000000000001296] [Reference Citation Analysis]
31 Huang A, Bange E, Han N, Wileyto EP, Kim J, Gouma S, Robinson J, Greenplate A, Porterfield F, Owoyemi O, Naik K, Zheng C, Galantino M, Weisman A, Ittner C, Kugler E, Baxter A, Weirick M, McAllister C, Babady NE, Kumar A, Widman A, Dewolf S, Boutemine S, Roberts C, Budzik K, Tollett S, Wright C, Perloff T, Sun L, Mathew D, Giles J, Oldridge D, Wu J, Alanio C, Adamski S, Vella L, Kerr S, Cohen J, Oyer R, Massa R, Maillard I, Maxwell K, Maslak P, Vonderheide R, Wolchok JD, Hensley S, Wherry E, Meyer N, DeMichele A, Vardhana S, Mamtani R, Oniyide O, Agyekum R, Dunn T, Jones T, Giannini H, Garfall A, Reilly J. CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer. Res Sq 2021:rs. [PMID: 33564756 DOI: 10.21203/rs.3.rs-162289/v1] [Cited by in Crossref: 9] [Article Influence: 9.0] [Reference Citation Analysis]
32 Stock PG, Henrich TJ, Segev DL, Werbel WA. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients. J Clin Invest 2021;131:151178. [PMID: 34143755 DOI: 10.1172/JCI151178] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Delgado-Fernández M, García-Gemar GM, Fuentes-López A, Muñoz-Pérez MI, Oyonarte-Gómez S, Ruíz-García I, Martín-Carmona J, Sanz-Cánovas J, Castaño-Carracedo MÁ, Reguera-Iglesias JM, Ruíz-Mesa JD. Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency - Three consecutive cases and review of the literature. Enferm Infecc Microbiol Clin (Engl Ed) 2021:S0213-005X(21)00035-5. [PMID: 33741148 DOI: 10.1016/j.eimc.2021.01.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
34 Galmiche S, Luong Nguyen LB, Tartour E, de Lamballerie X, Wittkop L, Loubet P, Launay O. Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review. Clin Microbiol Infect 2021:S1198-743X(21)00566-8. [PMID: 35020589 DOI: 10.1016/j.cmi.2021.09.036] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 24.0] [Reference Citation Analysis]
35 Hage R, Steinack C, Gautschi F, Pfister S, Inci I, Schuurmans MM. Clinical Characteristics, Treatments and Outcomes of 18 Lung Transplant Recipients with COVID-19. Transplantology 2021;2:229-45. [DOI: 10.3390/transplantology2020022] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Nimmo A, Gardiner D, Ushiro-lumb I, Ravanan R, Forsythe JLR. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic. Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/tp.0000000000004151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Naehrlich L, Orenti A, Dunlevy F, Kasmi I, Harutyunyan S, Pfleger A, Keegan S, Daneau G, Petrova G, Tješić-Drinković D, Yiallouros P, Bilkova A, Olesen HV, Burgel PR, Parulava T, Diamantea F, Párniczky A, McKone EF, Mei-Zahav M, Salvatore M, Colombo C, Aleksejeva E, Malakauskas K, Schlesser M, Fustik S, Turcu O, Zomer-van Ommen D, Wathne AS, Woźniacki Ł, Pereira L, Pop L, Kashirskaya N, Rodić M, Kayserova H, Krivecs U, Mondejar-Lopez P, de Monestrol I, Dogru D, Makukh H, Cosgriff R, van Koningsbruggen-Rietschel S, Jung A; European Cystic Fibrosis COVID project group. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020. J Cyst Fibros 2021;20:566-77. [PMID: 34016559 DOI: 10.1016/j.jcf.2021.03.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Quante M, Brake L, Tolios A, Della Penna A, Steidle C, Gruendl M, Grishina A, Haeberle H, Guthoff M, Tullius SG, Königsrainer A, Nadalin S, Löffler MW. SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020. Transplant Proc 2021;53:2421-34. [PMID: 34551880 DOI: 10.1016/j.transproceed.2021.08.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Garcia VD, Pêgo-Fernandes PM. Organ transplantation and COVID-19. Sao Paulo Med J 2021;139:301-4. [PMID: 34190892 DOI: 10.1590/1516-3180.2021.139420052021] [Reference Citation Analysis]
40 Forner-Puntonet M, Castell-Panisello E, Quintero J, Ariceta G, Gran F, Iglesias-Serrano I, Gisbert-Gustemps L, Daigre C, Ibañez-Jimenez P, Delgado M, Español-Martín G, Parramon G, Pont T, Ramos-Quiroga JA. Impact of COVID-19 on Families of Pediatric Solid Organ Transplant Recipients. J Pediatr Psychol 2021;46:927-38. [PMID: 34313783 DOI: 10.1093/jpepsy/jsab058] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Kute VB, Agarwal SK, Prakash J, Guleria S, Shroff S, Sharma A, Varma P, Prasad N, Sahay M, Gupta S, Sudhindran S, Krishan K, Ramesh V, Kumar S. NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients. Indian J Nephrol 2021;31:89-91. [PMID: 34267426 DOI: 10.4103/ijn.IJN_64_21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Magnusson JM, Larsson H, Alsaleh A, Ekelund J, Karason K, Schult A, Friman V, Felldin M, Søfteland JM, Dellgren G, Oltean M. COVID-19 in lung transplant recipients: an overview of the Swedish national experience. Transpl Int 2021. [PMID: 34709680 DOI: 10.1111/tri.14148] [Reference Citation Analysis]
43 Søfteland JM, Friman G, von Zur-Mühlen B, Ericzon BG, Wallquist C, Karason K, Friman V, Ekelund J, Felldin M, Magnusson J, Haugen Löfman I, Schult A, de Coursey E, Leach S, Jacobsson H, Liljeqvist JÅ, Biglarnia AR, Lindnér P, Oltean M. COVID-19 in solid organ transplant recipients: A national cohort study from Sweden. Am J Transplant 2021;21:2762-73. [PMID: 33811777 DOI: 10.1111/ajt.16596] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
44 Schaffrath J, Brummer C, Wolff D, Holtick U, Kröger N, Bornhäuser M, Kraus S, Hilgendorf I, Blau I, Penack O, Wittke C, Steiner N, Nachbaur D, Thurner L, Hindah H, Zeiser R, Maier C, Bethge W, Müller LP. High mortality of COVID-19 early after allogeneic stem cell transplantation – a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group. Transplantation and Cellular Therapy 2022. [DOI: 10.1016/j.jtct.2022.03.010] [Reference Citation Analysis]
45 Pinchera B, Spirito L, Ferreri L, Rocca R, Celentano G, Buonomo AR, Foggia M, Scotto R, Federico S, Gentile I, Carrano R; “Federico II” COVID-19 Team. SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience. Front Med (Lausanne) 2022;9:864865. [PMID: 35419375 DOI: 10.3389/fmed.2022.864865] [Reference Citation Analysis]
46 Yamani AH, Alraddadi BM, Almaghrabi RS, Amer AA, Mehdawi FS, Al-Hamzi MA, Aldajani MS, Alattas MS, Elsaed Ramadan AM, Wali GY, Alshukairi AN, Al Mutair A. Early use of tocilizumab in solid organ transplant recipients with COVID-19: A retrospective cohort study in Saudi Arabia. Immun Inflamm Dis 2022;10:e587. [PMID: 35029324 DOI: 10.1002/iid3.587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Kumar N, Rana R, Rana DS, Gupta A, Sachdeva MP. SARS-CoV-2 in Kidney Transplant Recipients: A Systematic Review. Transplantology 2022;3:33-48. [DOI: 10.3390/transplantology3010004] [Reference Citation Analysis]
48 Veterano C, Antunes I, Coelho A, Silva I, Almeida R, Pinto PS. Endovascular Treatment of Renal Artery Thrombosis in Living-Donor Kidney Transplant Recipient With Severe COVID-19 Disease. J Endovasc Ther 2022;:15266028211068756. [PMID: 34994219 DOI: 10.1177/15266028211068756] [Reference Citation Analysis]
49 Belsky JA, Tullius BP, Lamb MG, Sayegh R, Stanek JR, Auletta JJ. COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients. J Infect 2021;82:329-38. [PMID: 33549624 DOI: 10.1016/j.jinf.2021.01.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
50 Fida N. Management of Heart Failure, Durable Left Ventricular Assist Device, and Heart Transplant Patients in the COVID-19 Era. Methodist Debakey Cardiovasc J 2021;17:63-72. [PMID: 34992724 DOI: 10.14797/mdcvj.651] [Reference Citation Analysis]
51 Azu OO, Olojede SO, Lawal SK, Oseni SO, Rennie CO, Offo U, Naidu ECS. Novel severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection: Microbiologic perspectives and anatomic considerations for sanctuary sites. J Infect Public Health 2021;14:1237-46. [PMID: 34455307 DOI: 10.1016/j.jiph.2021.08.015] [Reference Citation Analysis]
52 Diaz-Arocutipa C, Carvallo-Castañeda D, Luis-Ybañez O, Pariona M, Rivas-Lasarte M, Álvarez-García J. COVID-19 in heart transplant recipients during February-August 2020: A systematic review. Clin Transplant 2021. [PMID: 34159650 DOI: 10.1111/ctr.14390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Focosi D, Franchini M. Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations. Expert Rev Vaccines 2021;:1-8. [PMID: 34015243 DOI: 10.1080/14760584.2021.1932475] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Karaba AH, Zhu X, Liang T, Wang KH, Rittenhouse AG, Akinde O, Eby Y, Ruff JE, Blankson JN, Abedon AT, Alejo JL, Cox AL, Bailey JR, Thompson EA, Klein SL, Warren DS, Garonzik-Wang JM, Boyarsky BJ, Sitaras I, Pekosz A, Segev DL, Tobian AAR, Werbel WA. A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients. medRxiv 2021:2021. [PMID: 34671774 DOI: 10.1101/2021.08.11.21261914] [Reference Citation Analysis]
55 Giannella M, Pierrotti LC, Helanterä I, Manuel O. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know. Transpl Int 2021;34:1776-88. [PMID: 34450686 DOI: 10.1111/tri.14029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Wightman A, Goldberg A, Diekema D. Considering a COVID-19 vaccine mandate for pediatric kidney transplant candidates. Pediatr Nephrol 2022. [PMID: 35333972 DOI: 10.1007/s00467-022-05511-7] [Reference Citation Analysis]
57 Devresse A, De Greef J, Yombi JC, Belkhir L, Goffin E, Kanaan N. Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients. Transplantation Direct 2022;8:e1292. [DOI: 10.1097/txd.0000000000001292] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
58 Ao G, Wang Y, Qi X, Nasr B, Bao M, Gao M, Sun Y, Xie D. The association between severe or death COVID-19 and solid organ transplantation: A systematic review and meta-analysis. Transplant Rev (Orlando) 2021;35:100628. [PMID: 34087553 DOI: 10.1016/j.trre.2021.100628] [Reference Citation Analysis]
59 van den Hoogen MWF, Seghers L, Manintveld OC, Roest S, Bekkers JA, den Hoed CM, Minnee RC, de Geus HRH, van Thiel RJ, Hesselink DA. Care for the organ transplant recipient on the intensive care unit. J Crit Care 2021;64:37-44. [PMID: 33784577 DOI: 10.1016/j.jcrc.2021.03.003] [Reference Citation Analysis]
60 Kittleson MM, Chambers DC, Cypel M, Potena L. Covid-19 in recipients of heart and lung transplantation: Learning from experience. J Heart Lung Transplant 2021;40:948-50. [PMID: 34246563 DOI: 10.1016/j.healun.2021.05.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Sigler R, Chen V, Law N. Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients. Curr Transplant Rep 2022;:1-14. [PMID: 35669887 DOI: 10.1007/s40472-022-00368-z] [Reference Citation Analysis]
62 Krishnasamy S, Mantan M, Mishra K, Kapoor K, Brijwal M, Kumar M, Sharma S, Swarnim S, Gaind R, Khandelwal P, Hari P, Sinha A, Bagga A. SARS-CoV-2 infection in children with chronic kidney disease. Pediatr Nephrol 2021. [PMID: 34519896 DOI: 10.1007/s00467-021-05218-1] [Reference Citation Analysis]
63 Meshram HS, Kute VB, Patel HV, Hegde U, Das P, Sil K, Sahay M, Raju SB, Chaudhury AR, Siddini V, Pathak V, Bahadur MM, Anand U, Krishna A, Abraham A, Patel AH, Mishra V, Chauhan S. Is Early COVID-19 in Kidney Transplant Recipients Concerning Enough to Halt Transplantation? A Multicenter Comparative Analysis from India. Transplant Proc 2021;53:2468-75. [PMID: 34556343 DOI: 10.1016/j.transproceed.2021.08.034] [Reference Citation Analysis]
64 Solera JT, Árbol BG, Alshahrani A, Bahinskaya I, Marks N, Humar A, Kumar D. Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave. Clin Infect Dis 2022:ciac324. [PMID: 35445690 DOI: 10.1093/cid/ciac324] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Goldman JD, Robinson PC, Uldrick TS, Ljungman P. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. J Immunother Cancer 2021;9:e002630. [PMID: 34117116 DOI: 10.1136/jitc-2021-002630] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Alfishawy M, Nso N, Nassar M, Ariyaratnam J, Bhuiyan S, Siddiqui RS, Li M, Chung H, Al Balakosy A, Alqassieh A, Fülöp T, Rizzo V, Daoud A, Soliman KM. Liver transplantation during global COVID-19 pandemic. World J Clin Cases 2021; 9(23): 6608-6623 [PMID: 34447809 DOI: 10.12998/wjcc.v9.i23.6608] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
67 Kuramitsu K, Yamanaga S, Osawa R, Hibi T, Yoshikawa M, Toyoda M, Shimata K, Yosuke E, Ono M, Kenmochi T, Sogawa H, Natori Y, Yano H, Chen-Yoshikawa T, Yoshida K, Fukumoto T, Yuzawa K, Egawa H. Impact of COVID-19 on the Living Donor Liver and Kidney Transplantation Programs in Japan in 2020. Transpl Infect Dis 2022. [PMID: 35505462 DOI: 10.1111/tid.13845] [Reference Citation Analysis]
68 Soni M, Migliori E, Assal A, Chan HT, Ciubotariu R, Pan JB, Cicero K, Pereira M, Mapara MY, Muranski P. Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection. Cytotherapy 2021:S1465-3249(21)00685-X. [PMID: 34183244 DOI: 10.1016/j.jcyt.2021.05.005] [Reference Citation Analysis]
69 Yılmaz EA, Özdemir Ö. Solid organ transplantations and COVID-19 disease. World J Transplant 2021; 11(12): 503-511 [DOI: 10.5500/wjt.v11.i12.503] [Reference Citation Analysis]
70 Vinson AJ, Anzalone AJ, Sun J, Dai R, Agarwal G, Lee SB, French E, Olex A, Ison MG, Mannon RB; N3C consortium. The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls. Am J Transplant 2022. [PMID: 35674237 DOI: 10.1111/ajt.17117] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Dogar AW, Uddin S, Ghaffar A, Abbas SH, Izzo H, Hussain A, Ullah K, Shoaib A, Ud Din S, Ahmed B, Hamza MA, Zafar M, Qaiser MA, Raza H, Baig MA, Husnain A, Mumtaz K. Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learned. BMJ Open Gastroenterol 2021;8:e000723. [PMID: 34670755 DOI: 10.1136/bmjgast-2021-000723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Dorfman L, Nassar R, Rozenfeld Bar-Lev M, Shafir M, Oseran I, Mozer-Glassberg Y, Gavish R, Assa A, Shamir R, Waisbourd-Zinman O. Treatment adherence and behavior of pediatric liver transplant recipients during the COVID-19 pandemic. Pediatr Transplant 2022;:e14250. [PMID: 35146853 DOI: 10.1111/petr.14250] [Reference Citation Analysis]
73 Franchini M, Corsini F, Focosi D, Cruciani M. Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews. Diagnostics (Basel) 2021;11:1663. [PMID: 34574004 DOI: 10.3390/diagnostics11091663] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Ng A. Graft injury and re-transplantation in liver transplant patients with COVID-19. Journal of Liver Transplantation 2021;1:100008. [DOI: 10.1016/j.liver.2021.100008] [Reference Citation Analysis]
75 Nassar M, Nso N, Ariyaratnam J, Sandhu J, Mohamed M, Baraka B, Ibrahim A, Alfishawy M, Zheng D, Bhangoo H, Soliman KM, Li M, Rizzo V, Daoud A. Coronavirus disease 2019 and renal transplantation. World J Clin Cases 2021; 9(27): 7986-7997 [PMID: 34621855 DOI: 10.12998/wjcc.v9.i27.7986] [Reference Citation Analysis]
76 Focosi D, Franchini M. COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review. Transfus Apher Sci 2021;60:103071. [PMID: 33518427 DOI: 10.1016/j.transci.2021.103071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
77 Grupper A, Katchman H. SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00359-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]